AnaptysBio has reported that the ARISE-AD trial of its investigational B and T lymphocyte attenuator (BTLA) agonist, ANB032, for treating moderate-to-severe atopic dermatitis (AD), also known as ...

Its most advanced project is MB272, an agonist of B- and T-lymphocyte attenuator (BTLA) which recently started phase 1 testing, and it has a PD-1 agonist called MB151 in late preclinical development.

The muscle that is contracting is called the agonist and the muscle that is relaxing or lengthening is called the antagonist. Key fact One way to remember which muscle is the agonist – it's the ...

About KGF alternative peptide (FGFR2b agonist) [Product code: PG-012] Mechanism of activating FGFR2b by the KGF alternative peptide (PG-012) PG-012, KGF alternative peptide, is a dimeric peptide ...